Profound Medical Corp.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
11.22 |
17.52 |
37.62 |
50.95 |
153.30 |
143.30 |
Przychód Δ r/r |
0.00% |
56.12% |
114.69% |
35.42% |
200.88% |
-6.52% |
Przychód (min) |
9.09 |
10.15 |
33.44 |
41.28 |
124.19 |
116.09 |
Przychód (max) |
13.99 |
22.77 |
49.27 |
63.49 |
191.03 |
178.57 |
EBITDA (średnia) |
-11.22 |
-17.52 |
-37.62 |
-50.95 |
-153.30 |
-143.30 |
EBIT (średnia) |
-11.22 |
-17.52 |
-37.62 |
-50.95 |
-153.30 |
-143.30 |
EBIT % |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
-100.00% |
Zysk netto (średni) |
-44.25 |
-48.48 |
-42.58 |
-53.85 |
40.79 |
14.31 |
Zysk netto % |
-394.22% |
-276.63% |
-113.16% |
-105.69% |
26.61% |
9.99% |
EPS (średnia) |
-1.79 |
-1.96 |
-1.72 |
-2.17 |
1.65 |
0.58 |
Liczba analityków (Przychody) |
2 |
4 |
5 |
2 |
1 |
2 |
Liczba analityków (EPS) |
3 |
3 |
5 |
1 |
2 |
1 |
symbol |
PROF |
PROF |
PROF |
PROF |
PROF |
PROF |